Patent No.

Patent Name

Legal Status

CN2004 80014 521.7

Hydroxyamidine- and hydroxyguanidine compounds as urokinase inhibitors

Granted

CN2005 80024944.1

Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanine-4-ethoxycarbonyl-piperazide and/or salts thereof

Granted

CN03804714.4

Method for the Production of phenylalanine derivatives in highly pure form

Granted

CN2005 80025625.2

Stable formulation for phenylalanine derivatives

Granted

CN2005 80035019.9

Method for cleaning 3-Hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid

Granted

HK07109145.8

Method for the Production of phenylalanine derivatives in highly pure form

Granted

HK07112086.3

Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanine-4-ethoxycarbonyl-piperazide and/or salts thereof

Granted

CN200610092558.2

Inflammation-inhibiting compounds

Granted

CN201010126136.9

Inflammation-inhibiting compounds

Granted

2015/067493 A1

Storage stable lyophilized tripeptide formulations

National Phase entered

CN200780006529.2

Substituted Indolopyridines as Eg5 Inhibitors

Granted

CN201080049904.3

Lipid layer forming composition for administration onto a surface of a living organism

Granted

The patents of Anson (3 patents) were not included in this table, neither were the trademarks of DermLab.